reports
Safilo Group: 1 director
A director at Safilo Group bought 25,000 shares at 0.780EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
- Cedric Rossi
- Clement Genelot
- Loic Morvan
On the shelves now: Consumer Weekly #63
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we look at how sub-sectors within our Consumer coverage have fared since the beginni
- Cedric Rossi
US eyewear: black tariff clouds looming over consumers
In our last report a month ago ("Trumping tariffs"), we were relatively optimistic as Donald Trump had only added a 10% tariff on Chinese imports and implemented a 30-day pause on tariffs for imports from Mexico and Canada. However, the situation has darkened since an additional 10% tariff has been
- Cedric Rossi
- Clement Genelot
- Loic Morvan
On the shelves now: Consumer Weekly #62
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we look at how Trump's trade war is negatively impacting US consumer sentiment. Happ
- Cedric Rossi
Safilo: encouraging start to the year despite macro uncertainty
The final FY24 results unveiled yesterday were in line with the pre-announced numbers on 28th January. Safilo recorded a positive start to 2025 in both Europe and North America, ahead of March, which is key for the Q1 performance. Although management refrained from providing detailed FY25 targets,
- Cedric Rossi
US eyewear: Trumping tariffs
With existing duties relatively low compared to other consumer categories, the potential new tariffs that could be imposed by incoming President Trump are naturally sparking concern across the US optical industry. At this stage, we are optimistic about the sector's ability to navigate tariffs: (i)
- Cedric Rossi
- Clement Genelot
- Loic Morvan
On the shelves now: Consumer Weekly #56
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we look at how US tourism could drive European luxury sales, especially if Trump imp
- Cedric Rossi
Safilo: another good surprise on Q4 margins
Preliminary FY24 numbers unveiled yesterday confirmed that Q4 trends were on par with the 9M trajectory with a FX-n sales decline due to the phase-out of Jimmy Choo, and another margin beat. FCF generation was also impressive. Ahead of FY25 results due on 11th March, we stick to our scenario for fu
- Cedric Rossi
Eyewear: what caught our eyes in Q3 publications
Q3 publications were generally more mixed than previous quarters with many players flagging polarised consumer behaviour even in the traditionally defensive prescription category. Most companies were relatively optimistic about Q4 thanks to easier comparatives and a more favourable category-mix, wh
- Cedric Rossi
- Clement Genelot
- Loic Morvan
- Philippine Adam
On the shelves now: Consumer Weekly #47
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week we look at the impact of Donald Trump's election. Happy reading!
- Cedric Rossi
US eyewear: groups embrace the holiday season with cautious optimism
This week, National Vision (NV) and Warby Parker (WRBY) both reported positive Q3 numbers, confirming the first signs of stabilisation within the US eyewear market as the two players address different customer bases and price points. Obviously it was too early to draw conclusions from Trump's win o
- Cedric Rossi
Safilo: Q3 continuation of Q2, promising growth in October
Q3 numbers unveiled yesterday evening were a continuation of Q2 trends with continued margin improvement despite a 3.4% FX-n sales decline (flat growth ex-Jimmy Choo). During the call, management was cautiously optimistic on the back of all regions growing in October but the remainder of the quarte
- Cedric Rossi
OTC hearing aid market: no worms in the Apple
Among all the innovative products presented at Monday's Apple Keynote, the AirPods Pro 2 stood out for the new OTC hearing aid capability to be included for users with mild to moderate hearing loss, representing EUR1.4bn people globally. While most hearing aid stocks and, to a lesser extent, Essilo
- Cedric Rossi
US eyewear: watch out for inflation-weary consumers
Although eyewear players operate in a durable category that enjoys a relatively defensive status, US consumers showed signs of flagging in Q2 as pent-up demand in prescription did not materialise and the sunglass category suffered subdued trends. This cautious behaviour was particularly visible amo
- Cedric Rossi
Safilo: weak sales trends as in Q1 but resilient margins in Q2 2024
Yesterday evening, Safilo reported Q2 numbers showing similar trends to Q1: a FX-n sales decline of 3.1% with a greater negative impact from the phase-out of Jimmy Choo (-3 to -4pp) whereas GM and aEBITDA margin continued to improve. With July showing no inflection point, we expect improving sales
- Cedric Rossi
- Clement Genelot
- Loic Morvan
- Paul Rouviere
- Philippine Adam
On the shelves now: Consumer weekly #36
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we look at the US job market that is gradually cooling, prompting investors to bet o
- Cedric Rossi
Eyewear: A photochromic first half
On par with these lenses that turn from dark-to-clear, we expect ambivalent performances for EssilorLux (ESLX) and Safilo (SFL) in H1 2024: the former should post strong top-line momentum in Q2 combined with a flat H1 aEBIT margin, whereas SFL's Q2 sales trends will be mainly impacted by the phase-
- Cedric Rossi
- Clement Genelot
- Loic Morvan
- Paul Rouviere
- Philippine Adam
On the shelves now: Consumer weekly #28
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we comment about the positive stock market trend in spite of constant delays in Fed
- Cedric Rossi
US eyewear: Distinct Q1 trajectories between NV and Warby Parker
Except for National Vision which faced company-specific issues, Q1 proved to be a reassuring vintage for most optical players, despite several headwinds such as the "Artic Blast" in January and the earlier Easter that mainly impacted prescription sales. Relative optimism continues to prevail for 20
- Cedric Rossi
Safilo: Q1 less negative than feared and reassuring month of April
The Q1 sales decline of 1.8% FX-n was less damaging than our -4.6% FX-n figure (see our preview here) thanks to a stronger-than-expected performance in Europe. Q1 aEBITDA margin also surprised positively with a 20bp-improvement to 11.5% (CSSe: 11.2% / BGe: 11.3%). Management confirmed a return to p
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.